The University of California's patent infringement suit against Genentech Inc. over human growth hormone has completed closing arguments in the U.S. District Court for the Northern District of California and is now before a jury to decide.

At issue is whether GNE (South San Francisco, Calif.) infringed the university's U.S. Patent No. 4,363,877 covering the hGH gene in the manufacturing of GNE's Protropin somatrem hGH, which was launched in the U.S. in 1985. GNE's hGH products last year posted